|
Volumn 12, Issue 2, 2015, Pages 2511-2520
|
Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CCL17 PROTEIN, MOUSE;
CCL22 PROTEIN, MOUSE;
MACROPHAGE DERIVED CHEMOKINE;
NEUTRALIZING ANTIBODY;
OVALBUMIN;
THYMUS AND ACTIVATION REGULATED CHEMOKINE;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
ASTHMA;
BAGG ALBINO MOUSE;
BIOSYNTHESIS;
CELL DIFFERENTIATION;
CELL MOTION;
CHEMICALLY INDUCED;
DENDRITIC CELL;
DISEASE MODEL;
DRUG EFFECTS;
FEMALE;
HUMAN;
IMMUNOLOGY;
LUNG;
LYMPH NODE;
LYMPHOCYTE ACTIVATION;
MESENCHYMAL STEM CELL TRANSPLANTATION;
MESENCHYMAL STROMA CELL;
MOUSE;
PATHOLOGY;
TH2 CELL;
ANIMALS;
ANTIBODIES, NEUTRALIZING;
ASTHMA;
CELL DIFFERENTIATION;
CELL MOVEMENT;
CHEMOKINE CCL17;
CHEMOKINE CCL22;
DENDRITIC CELLS;
DISEASE MODELS, ANIMAL;
FEMALE;
HUMANS;
LUNG;
LYMPH NODES;
LYMPHOCYTE ACTIVATION;
MESENCHYMAL STEM CELL TRANSPLANTATION;
MESENCHYMAL STROMAL CELLS;
MICE;
MICE, INBRED BALB C;
OVALBUMIN;
TH2 CELLS;
|
EID: 85018214943
PISSN: None
EISSN: 17913004
Source Type: Journal
DOI: 10.3892/mmr.2015.3706 Document Type: Article |
Times cited : (45)
|
References (0)
|